HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

W Y Zou Selected Research

CBV protocol

9/2019[High dose melphalan (HDM) is superior to cyclophosphamide plus etoposide and busulfan (CVB) as the conditioning regimen in autologous stem cell transplantation for multiple myeloma].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


W Y Zou Research Topics

Disease

3Multiple Myeloma
02/2022 - 06/2019
1Fever (Fevers)
09/2019
1Neoplasms (Cancer)
09/2019
1Residual Neoplasm
09/2019
1Amnesia (Dissociative Amnesia)
10/2014

Drug/Important Bio-Agent (IBA)

1Busulfan (Busulfex)FDA Link
09/2019
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2019
1Etoposide (VP 16)FDA LinkGeneric
09/2019
1Anti-Bacterial Agents (Antibiotics)IBA
09/2019
1Melphalan (Alkeran)FDA LinkGeneric
09/2019
1Bortezomib (Velcade)FDA Link
06/2019
1IsofluraneFDA LinkGeneric
10/2014

Therapy/Procedure

2Hematopoietic Stem Cell Transplantation
02/2022 - 06/2019
1CBV protocol
09/2019
1Transplantation
09/2019
1Stem Cell Transplantation
09/2019
1Induction Chemotherapy
06/2019
1Therapeutics
06/2019